Trials / Unknown
UnknownNCT00239954
Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder
Fixed Dose Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Pharmacology Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to evaluate the effectiveness, safety and tolerability of an escitalopram combination treatment compared to single treatments, and to placebo in patients with major depressive disorder.
Detailed description
Both active drugs being tested, alone and in combination, in this study are currently available antidepressants. However, the doses used in this study are lower than the standard approved doses.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Escitalopram |
Timeline
- Start date
- 2005-03-01
- First posted
- 2005-10-17
- Last updated
- 2012-05-09
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00239954. Inclusion in this directory is not an endorsement.